Naloxone Access: Answering Questions with the U.S. Food & Drug Administration Opioid epidemicSubstance use disorderHealthcare ProfessionalEducators and caregivers Mar 17 Written By Denise Kolakowski FDA Has Taken Several Steps in Recent Years to Support Increased Availability of Opioid Overdose Reversal Drug Learn more and register for meeting Denise Kolakowski
Naloxone Access: Answering Questions with the U.S. Food & Drug Administration Opioid epidemicSubstance use disorderHealthcare ProfessionalEducators and caregivers Mar 17 Written By Denise Kolakowski FDA Has Taken Several Steps in Recent Years to Support Increased Availability of Opioid Overdose Reversal Drug Learn more and register for meeting Denise Kolakowski